The Must-Know Finance Concepts for Life Sciences Valuations - Part 2

This is part 2 of the webinar where we go into more detail on the key finance concepts and most common methodologies used to evaluate life sciences assets.

In this webinar, you’ll learn:

  • Valuation methodology most used by big pharma

  • The 3 fundamental concepts in valuation

  • Cash flow examples for different situations

  • And more

WEBINAR replay

By supplying my contact information, I authorize ShareVault to contact me about relevant content, products, and services. We're committed to your privacy, for more information, check out our  Privacy Policy .


ShareVault’s secure document sharing solution gives organizations of all sizes in all industries the confidence to simply and securely share sensitive documents with third parties during due diligence, fundraising, board communications, and any circumstance when it is crucial that confidential information is maintained under the highest level of security and control.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.


Company team

John Selig

Co-Founder and Managing Partner of Mavericks Capital

John advises life sciences companies on M&A, licensing and financial strategy. He teaches the valuation and finance module at BIO’s Executive Management course for BD professionals and at Stanford Medical School’s Entrepreneurship program. Learn More

Company team

Jeff Karan

Co-Founder and Managing Partner of Mavericks Capital

Jeff brings over 30 years of investment banking and corporate advisory experience to Mavericks Capital.  In addition to his extensive knowledge of capital raising and merger & acquisitions, Jeff has advised clients on corporate strategy, business valuation, and a wide range of strategic partnership structures. Learn More